Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/08/2023 | PMV Pharmaceuticals, Inc. | PMVP | Grant | Stock Option (right to buy) | 21.5k | $5.59 | $120.2k | | 06/08/2023 |
06/08/2023 | PMV Pharmaceuticals, Inc. | PMVP | Gift | Stock Option (right to buy) | 21.5k | $5.59 | $120.2k | | 06/08/2023 |
06/08/2023 | PMV Pharmaceuticals, Inc. | PMVP | Gift | Stock Option (right to buy) | 21.5k | $5.59 | $120.2k | See footnote | 06/08/2023 |
05/31/2023 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
11/22/2022 | Frazier Lifesciences Acquisition Corp | | Exercise | Class B Ordinary Shares | 30k | $0.00 | $0 | | 11/22/2022 |
11/05/2022 | PMV Pharmaceuticals, Inc. | PMVP | Gift | Stock Option (right to buy) | 39k | $11.28 | $439.9k | See footnote | 11/04/2022 |
11/05/2022 | PMV Pharmaceuticals, Inc. | PMVP | Gift | Stock Option (right to buy) | 39k | $11.28 | $439.9k | | 11/04/2022 |
11/04/2022 | PMV Pharmaceuticals, Inc. | PMVP | Grant | Stock Option (right to buy) | 39k | $11.28 | $439.9k | | 11/04/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 8.5k | $65.39 | $555.8k | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 8.5k | $65.64 | $557.9k | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 30k | $39.99 | $1.2M | By the Gallagher Revocable Trust dated May 10, 2011 | 08/17/2022 |
06/23/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 31.5k | $7.35 | $231.5k | | 06/23/2022 |
06/23/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 20.5k | $0.00 | $0 | | 06/23/2022 |
06/15/2021 | Certara, Inc. | | Grant | Common Stock | 7.1k | $0.00 | $0 | | 06/15/2021 |
06/08/2021 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 17.5k | $13.80 | $241.5k | | 06/08/2021 |
06/08/2021 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 11k | $0.00 | $0 | | 06/08/2021 |
06/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 8.5k | $65.64 | $557.9k | | 06/02/2021 |
06/22/2020 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 12k | $2.40 | $28.8k | | 06/22/2020 |
06/16/2020 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 24.5k | $10.54 | $258.2k | | 06/16/2020 |
06/16/2020 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 8k | $0.00 | $0 | | 06/16/2020 |
06/15/2020 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 8.5k | $65.39 | $555.8k | | 06/15/2020 |
08/27/2019 | Turning Point Therapeutics, Inc. | TPTX | Gift | Stock Option (right to buy) | 30k | $39.99 | $1.2M | | 06/15/2020 |
08/27/2019 | Turning Point Therapeutics, Inc. | TPTX | Gift | Stock Option (right to buy) | 30k | $39.99 | $1.2M | By the Gallagher Revocable Trust dated May 10, 2011 | 06/15/2020 |
07/24/2019 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 30k | $39.99 | $1.2M | | 07/24/2019 |
06/27/2019 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 4k | $0.00 | $0 | | 06/27/2019 |
06/27/2019 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 13k | $20.25 | $263.2k | | 06/27/2019 |
06/20/2019 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 12k | $11.59 | $139.1k | | 06/20/2019 |
01/15/2019 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 6k | $8.80 | $52.8k | | 01/15/2019 |
12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 8.2k | $0.00 | $0 | | 12/07/2018 |
12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 23.7k | $0.00 | $0 | By: Gallagher Revocable Trust | 12/07/2018 |
11/07/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 21.4k | $36.38 | $777.6k | | 11/07/2018 |
06/18/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 2.1k | $44.68 | $93.8k | | 06/18/2018 |
06/18/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 400 | $45.29 | $18.1k | | 06/18/2018 |
06/14/2018 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 1.5k | $0.00 | $0 | | 06/14/2018 |
|